Skip to main content
Top

Journal of Bone and Mineral Metabolism

Issue 1/2001

Content (11 Articles)

Original articles

Biosynthesis of proteoglycan in bone and cartilage of parathyroid hormone-related protein knockout mice

Yuji Ogihara, Naoto Suda, Vicki E. Hammond, Paul V. Senior, Felix Beck, Masaki Yanagishita

In vivo bone-forming capacity of human bone marrow-derived stromal cells is stimulated by recombinant human bone morphogenetic protein-2

Hiroshi Yamagiwa, Naoto Endo, Kunihiko Tokunaga, Tadashi Hayami, Hiroshi Hatano, Hideaki E. Takahashi

Biochemical markers for the detection of bone metastasis in patients with prostate cancer: diagnostic efficacy and the effect of hormonal therapy

Tsutomu Tamada, Teruki Sone, Tatsushi Tomomitsu, Yoshimasa Jo, Hiroyoshi Tanaka, Masao Fukunaga

Measurement of bone mineral density of lumbar spine and whole body in low-birth-weight infants: comparison of two methods

Hiroyuki Ichiba, Chie Hirai, Mutsuko Fujimaru, Haruo Shintaku, Tsunekazu Yamano, Masahisa Funato

Case report

Oncogenic osteomalacia secondary to nasal tumor with decreased urinary excretion of cAMP

Yukana Kawai, Shigeto Morimoto, Katsuhiko Sakaguchi, Haruhito Yoshino, Takamori Yotsui, Seiichi Hirota, Hidenori Inohara, Takashi Nakagawa, Kenji Hattori, Takeshi Kubo, Jin Yang, Noriko Fujiwara, Toshio Ogihara

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine